Publications by authors named "Kate Maclagan"

Claim this Profile
M
Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseases.
Christine Girges, Nirosen Vijiaratnam, Alexa King, Grace Auld, Rachel McComish, Kate Maclagan

Clin Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification Trials.
Nirosen Vijiaratnam, Christine Girges, Dilan Athauda, Alexa King, Grace Auld, Kate Maclagan

Mov Disord Clin Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia.
Moritz Döbert, Anna Nektaria Varouxaki, An Chi Mu, Argyro Syngelaki, Anca Ciobanu, Kate Maclagan

Circulation· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study.
Nirosen Vijiaratnam, Christine Girges, Grace Auld, Marisa Chau, Kate Maclagan

BMJ Open· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
Anoop Rehal, Zsófia Benkő, Catalina De Paco Matallana, Argyro Syngelaki, Deepa Janga, Kate Maclagan

Am J Obstet Gynecol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc Analysis.
Dilan Athauda, Kate Maclagan, Natalia Budnik, Luca Zampedri, Steve Hibbert

J Parkinsons Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
Adrian J Hobbs, Amie J Moyes, Reshma S Baliga, Dipa Ghedia, Rachel Ochiel, Kate Maclagan

Br J Pharmacol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analysis of the Exenatide-PD trial-Factors that predict response.
Dilan Athauda, Kate Maclagan, Natalia Budnik, Luca Zampedri, Steve Hibbert

Eur J Neurosci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford

Lancet· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia.
Daniel L Rolnik, David Wright, Liona C Poon, Neil O'Gorman, Argyro Syngelaki, Kate Maclagan

N Engl J Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combinatorial method to enable detailed investigation of protein-protein interactions.
Kate Maclagan, Rita Tommasi, Emmanuelle Laurine, Chrisostomos Prodromou, Paul C Driscoll

Future Med Chem· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.
Assia Merabet, Hellen Houlleberghs, Kate Maclagan, Ester Akanho, Tam T T Bui

Biochem J· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Domain Hunting: An effective approach for the identification of soluble protein domains adaptable to high-throughput applications.
Stefanie Reich, Loretto H Puckey, Caroline L Cheetham, Richard Harris, Ammar A E Ali, Kate Maclagan

Protein Sci· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis